184 related articles for article (PubMed ID: 28054368)
21. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease.
Dial S; Delaney JA; Barkun AN; Suissa S
JAMA; 2005 Dec; 294(23):2989-95. PubMed ID: 16414946
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of zoonotic Salmonella and Campylobacter gastroenteritis in patients with haematological malignancies: a population-based study.
Gradel KO; Nørgaard M; Dethlefsen C; Schønheyder HC; Kristensen B; Ejlertsen T; Nielsen H
Ann Hematol; 2009 Aug; 88(8):761-7. PubMed ID: 19083236
[TBL] [Abstract][Full Text] [Related]
23. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study.
Andersen AB; Erichsen R; Farkas DK; Mehnert F; Ehrenstein V; Sørensen HT
Aliment Pharmacol Ther; 2012 May; 35(10):1190-8. PubMed ID: 22443179
[TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitor and histamine-2 receptor antagonist use and risk of liver cancer in two population-based studies.
Tran KT; McMenamin ÚC; Hicks B; Murchie P; Thrift AP; Coleman HG; Iversen L; Johnston BT; Lee AJ; Cardwell CR
Aliment Pharmacol Ther; 2018 Jul; 48(1):55-64. PubMed ID: 29741272
[TBL] [Abstract][Full Text] [Related]
25. Use of proton pump inhibitors and histamine-2 receptor antagonists and risk of gastric cancer in two population-based studies.
Liu P; McMenamin ÚC; Johnston BT; Murchie P; Iversen L; Lee AJ; Vissers PAJ; Cardwell CR
Br J Cancer; 2020 Jul; 123(2):307-315. PubMed ID: 32367073
[TBL] [Abstract][Full Text] [Related]
26. Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.
Gradel KO; Nielsen HL; Schønheyder HC; Ejlertsen T; Kristensen B; Nielsen H
Gastroenterology; 2009 Aug; 137(2):495-501. PubMed ID: 19361507
[TBL] [Abstract][Full Text] [Related]
27. Observational cohort study: safety outcomes in children using proton pump inhibitors or histamine-2 receptor antagonists.
Houben E; Johansson S; Nagy P; Penning-van Beest FJA; Kuipers EJ; Herings RMC
Curr Med Res Opin; 2018 Apr; 34(4):577-583. PubMed ID: 29149805
[TBL] [Abstract][Full Text] [Related]
28. Proton pump inhibitors and gastroenteritis.
Hassing RJ; Verbon A; de Visser H; Hofman A; Stricker BH
Eur J Epidemiol; 2016 Oct; 31(10):1057-1063. PubMed ID: 26960438
[TBL] [Abstract][Full Text] [Related]
29. Association between proton pump inhibitors use and risk of hip fracture: A general population-based cohort study.
Wei J; Chan AT; Zeng C; Bai X; Lu N; Lei G; Zhang Y
Bone; 2020 Oct; 139():115502. PubMed ID: 32593677
[TBL] [Abstract][Full Text] [Related]
30. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
31. Exposure to acid-suppressing drugs during pregnancy and the risk of asthma in childhood: an observational cohort study.
Cea Soriano L; Hernández-Díaz S; Johansson S; Nagy P; García-Rodríguez LA
Aliment Pharmacol Ther; 2016 Feb; 43(3):427-37. PubMed ID: 26612701
[TBL] [Abstract][Full Text] [Related]
32. Acid-suppressive medication use in acute stroke and hospital-acquired pneumonia.
Herzig SJ; Doughty C; Lahoti S; Marchina S; Sanan N; Feng W; Kumar S
Ann Neurol; 2014 Nov; 76(5):712-8. PubMed ID: 25164323
[TBL] [Abstract][Full Text] [Related]
33. Comparative Evaluation of Enteric Bacterial Culture and a Molecular Multiplex Syndromic Panel in Children with Acute Gastroenteritis.
Kellner T; Parsons B; Chui L; Berenger BM; Xie J; Burnham CA; Tarr PI; Lee BE; Nettel-Aguirre A; Szelewicki J; Vanderkooi OG; Pang XL; Zelyas N; Freedman SB
J Clin Microbiol; 2019 Jun; 57(6):. PubMed ID: 30971465
[TBL] [Abstract][Full Text] [Related]
34. Acid suppressants use and the risk of dementia: A population-based propensity score-matched cohort study.
Wu CL; Lei WY; Wang JS; Lin CE; Chen CL; Wen SH
PLoS One; 2020; 15(11):e0242975. PubMed ID: 33253311
[TBL] [Abstract][Full Text] [Related]
35. [Investigation of verotoxigenic Escherichia coli O157:H7 incidence in gastroenteritis patients].
Erdoğan H; Levent B; Erdoğan A; Güleşen R; Arslan H
Mikrobiyol Bul; 2011 Jul; 45(3):519-25. PubMed ID: 21935785
[TBL] [Abstract][Full Text] [Related]
36. Association Between Acute Gastroenteritis and Continuous Use of Proton Pump Inhibitors During Winter Periods of Highest Circulation of Enteric Viruses.
Vilcu AM; Sabatte L; Blanchon T; Souty C; Maravic M; Lemaitre M; Steichen O; Hanslik T
JAMA Netw Open; 2019 Nov; 2(11):e1916205. PubMed ID: 31774521
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and antimicrobial susceptibility of Salmonella and Shigella spp. among children with gastroenteritis in an Iranian referral hospital.
Mahmoudi S; Pourakbari B; Moradzadeh M; Eshaghi H; Ramezani A; Haghi Ashtiani MT; Keshavarz Valian S; Mamishi S
Microb Pathog; 2017 Aug; 109():45-48. PubMed ID: 28526638
[TBL] [Abstract][Full Text] [Related]
38. Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel Disease.
Hanada Y; Khanna S; Loftus EV; Raffals LE; Pardi DS
Clin Gastroenterol Hepatol; 2018 Apr; 16(4):528-533. PubMed ID: 29037938
[TBL] [Abstract][Full Text] [Related]
39. High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study.
Nielsen HL; Ejlertsen T; Engberg J; Nielsen H
Clin Microbiol Infect; 2013 May; 19(5):445-50. PubMed ID: 22512739
[TBL] [Abstract][Full Text] [Related]
40. Study of the association between hip fracture and acid-suppressive drug use in a UK primary care setting.
Cea Soriano L; Ruigómez A; Johansson S; García Rodríguez LA
Pharmacotherapy; 2014 Jun; 34(6):570-81. PubMed ID: 24634193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
